OLUBUKOLA YOADE: Open Payments
NPI 1396328308 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 3 payments from 3 companies in 2025. Trend: 2023 $934 · 2024 $792 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $88 |
| Janssen Pharmaceuticals, Inc | 1 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Auvelity, INVEGA, CAPLYTA.
Industry payments across WA — which companies pay providers there.
